Skip to search formSkip to main contentSkip to account menu

CI 986

Known as: CI-986, Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 5-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)-1,3,4-thiadiazole-2(3H)-thione (1:1) 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Thiadiazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Role of Leukotrienes on Coronary Vasoconstriction in Isolated Hearts of Arthritic Rats: Effect of in vivo Treatment with CI-986, a Dual Inhibitor of Cyclooxygenase and Lipoxygenase
In this study, coronary perfusion pressure and force of contraction were investigated in isolated hearts removed from arthritic… 
1995
1995
Stimulus-dependent effects of CI-986 on arachidonic acid metabolism by human neutrophils
CI-986 (5-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1,3,4-thiadiazole-2(3H)-thione, choline salt) was evaluated for its effect… 
1994
1994
The pharmacologic effects of 5-[3,5-bis(1,1-dimethylethyl)-4- hydroxyphenyl]-1,3,4-thiadiazole-2(3H)-thione, choline salt (CI-986), a novel inhibitor of arachidonic acid metabolism in models of…
1993
1993
Subacute and subchronic toxicology studies of CI-986, a novel anti-inflammatory compound.
CI-986 (5-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1,3,4-thiadiazole-2(3H)- thione-2-hydroxy-N,N,N-trimethylethanaminium salt… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)